UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 386

Sortiert nach

Wavelength‐Selective Photopolymerization of Hybrid Acrylate‐Oxetane Liquid Crystals

Angewandte Chemie (International ed.), 2021-05, Vol.60 (19), p.10935-10941

International ed. in English, 2021

Volltextzugriff (PDF)

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.914-921

2009

Volltextzugriff (PDF)

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial

Annals of the rheumatic diseases, 2013-01, Vol.72 (1), p.72-78

2013

Volltextzugriff (PDF)

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

Annals of the rheumatic diseases, 2014-07, Vol.73 (7), p.1331-1339

2014

Volltextzugriff (PDF)

Effects of psychosocial factors on monitoring treatment effect in newly diagnosed rheumatoid arthritis patients over time: response data from the tREACH study

Scandinavian journal of rheumatology, 2018-05, Vol.47 (3), p.178-184

2018

Volltextzugriff (PDF)

A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study

Annals of the rheumatic diseases, 2011-01, Vol.70 (1), p.168-171

2011

Volltextzugriff (PDF)

Abtrünnig wider Willen (Buschak)

1993, 2018, p.473-475

Originally published 1995, 2018

Volltextzugriff (PDF)

Wavelength‐Selective Photopolymerization of Hybrid Acrylate‐Oxetane Liquid Crystals

Angewandte Chemie, 2021-05, Vol.133 (19), p.11030-11036

2021

Volltextzugriff (PDF)

SAT0111 Induction therapy with a combination of dmards is superior to methotrexate mono-therapy, unbiased for corticosteroids

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.507-508

2013

Volltextzugriff (PDF)

Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial)

Annals of the rheumatic diseases, 2007-09, Vol.66 (9), p.1227-1232

2007

Volltextzugriff (PDF)

Association of Low Baseline Levels of Erythrocyte Folate With Treatment Nonresponse at Three Months in Rheumatoid Arthritis Patients Receiving Methotrexate

Arthritis and rheumatism, 2013-11, Vol.65 (11), p.2803-2813

2013

Volltextzugriff (PDF)

Treatment decisions and related costs differ significantly depending on the choice of a disease activity index in RA, according to 1987 and 2010 classification criteria

Rheumatology (Oxford, England), 2012-07, Vol.51 (7), p.1269-1277

2012

Volltextzugriff (PDF)

Catastrophic manifestation of the antiphospholipid syndrome

Journal of rheumatology, 1999-10, Vol.26 (10), p.2261

1999

Volltextzugriff (PDF)

Factor Analysis of the Level of Expressed Emotion Scale, A Questionnaire Intended to Measure ‘Perceived Expressed Emotion’

British journal of psychiatry, 1992-03, Vol.160 (3), p.385-389

1992

Volltextzugriff (PDF)

Treatment with a Chimeric CD4 Monoclonal Antibody is Associated with a Relative Loss of CD4+/CD45RA+Cells in Patients with Rheumatoid Arthritis

Journal of autoimmunity, 1997-02, Vol.10 (1), p.87-97

1997

Volltextzugriff (PDF)

Treatment of Rheumatoid Arthritis with a Chimeric CD4 Monoclonal Antibody (cM‐T412): Immunopharmacological Aspects and Mechanisms of Action

Scandinavian journal of immunology, 1994-03, Vol.39 (3), p.286-294

1994

Volltextzugriff (PDF)

Flexion contractures associated with a malignant neoplasm: 'A paraneoplastic syndrome?'

Clinical rheumatology, 1998-01, Vol.17 (2), p.157-159

1998

Volltextzugriff (PDF)

Monoclonal antibody therapy of inflammatory rheumatic diseases

British medical bulletin, 1995-04, Vol.51 (2), p.493-502

1995

Volltextzugriff (PDF)

The likelihood of attaining and maintaining DMARD-free remission for various (rheumatoid) arthritis phenotypes

Rheumatology (Oxford, England), 2022-05, Vol.61 (6), p.2275-2284

2022

Volltextzugriff (PDF)

Measurement of synovial inflammation in rheumatoid arthritis with technetium 99m labelled human polyclonal immunoglobulin G

European Journal of Nuclear Medicine, 1991-02, Vol.18 (2), p.119-123

1991

Volltextzugriff (PDF)

Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis

Arthritis and rheumatism, 1995-10, Vol.38 (10), p.1457-1465

1995

Volltextzugriff (PDF)

On the psychometric properties of the life regard index (LRI): A measure of meaningful life: An evaluation in three independent samples based on the Dutch version

Personality and individual differences, 1993, Vol.14 (2), p.337-345

1993

Volltextzugriff (PDF)

A randomized, double‐blind, placebo‐controlled study of cd4 monoclonal antibody therapy in early rheumatoid arthritis

Arthritis and rheumatism, 1995-08, Vol.38 (8), p.1097-1106

1995

Volltextzugriff (PDF)

Anti-CD4 therapy in rheumatoid arthritis

Clinical and experimental rheumatology, 1993-03, Vol.11 Suppl 8, p.S151

1993

Volltextzugriff (PDF)

99mTc human immunoglobulin scintigraphy--a reliable method to detect joint activity in rheumatoid arthritis

Journal of rheumatology, 1992-09, Vol.19 (9), p.1371

1992

Volltextzugriff (PDF)

1 – 25 von 386

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(331)
Mit Volltextzugriff
(321)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Wavelength‐Selective Photopolymerization of Hybrid Acrylate‐Oxetane Liquid Crystals

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

Effects of psychosocial factors on monitoring treatment effect in newly diagnosed rheumatoid arthritis patients over time: response data from the tREACH study

A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study

Abtrünnig wider Willen (Buschak)

Wavelength‐Selective Photopolymerization of Hybrid Acrylate‐Oxetane Liquid Crystals

SAT0111 Induction therapy with a combination of dmards is superior to methotrexate mono-therapy, unbiased for corticosteroids

Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial)

Association of Low Baseline Levels of Erythrocyte Folate With Treatment Nonresponse at Three Months in Rheumatoid Arthritis Patients Receiving Methotrexate

Treatment decisions and related costs differ significantly depending on the choice of a disease activity index in RA, according to 1987 and 2010 classification criteria

Catastrophic manifestation of the antiphospholipid syndrome

Factor Analysis of the Level of Expressed Emotion Scale, A Questionnaire Intended to Measure ‘Perceived Expressed Emotion’

Treatment with a Chimeric CD4 Monoclonal Antibody is Associated with a Relative Loss of CD4+/CD45RA+Cells in Patients with Rheumatoid Arthritis

Treatment of Rheumatoid Arthritis with a Chimeric CD4 Monoclonal Antibody (cM‐T412): Immunopharmacological Aspects and Mechanisms of Action

Flexion contractures associated with a malignant neoplasm: 'A paraneoplastic syndrome?'

Monoclonal antibody therapy of inflammatory rheumatic diseases

The likelihood of attaining and maintaining DMARD-free remission for various (rheumatoid) arthritis phenotypes

Measurement of synovial inflammation in rheumatoid arthritis with technetium 99m labelled human polyclonal immunoglobulin G

Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis

On the psychometric properties of the life regard index (LRI): A measure of meaningful life: An evaluation in three independent samples based on the Dutch version

A randomized, double‐blind, placebo‐controlled study of cd4 monoclonal antibody therapy in early rheumatoid arthritis

Anti-CD4 therapy in rheumatoid arthritis

99mTc human immunoglobulin scintigraphy--a reliable method to detect joint activity in rheumatoid arthritis

Suchergebnisse filtern